TCR2 Therapeutics (TCRR) Stock Forecast

Analyst ratings, price targets, and earnings estimates.

TCRR Analyst Ratings

Hold

Consensus

Strong Buy
0
Buy
2
Hold
5
Sell
0
Strong Sell
0
29%71%

Based on 7 analysts in the past 3 months

TCRR Stock 12 Month Forecast

$0.00

▼ (0.00% Downside)
Highest Price Target
$5.00 (237.8%)
Average Price Target
$0.00 (0.0%)
Lowest Price Target
$5.00 (237.8%)

Based on 0 analysts in the last year

Recent Price Targets
554433221100Price Target ($)17 Jan17 Jan18 Jan18 Jan19 Jan19 Jan20 Jan20 Jan
Recommendation Trends
Strong Buy
Buy
Hold
Sell
Strong Sell
101088664422003167Jan 1, 2023Jan 1, 2023Feb 1, 2023Feb 1, 2023Mar 1, 2023Mar 1, 2023Apr 1, 2023Apr 1, 2023May 1, 2023May 1, 2023Jun 1, 2023Jun 1, 2023
Latest Price Target Updates
Date Analyst Firm Price Target Price When Posted Upside
Jan 19, 2022 Madhu Kumar Goldman Sachs $5.00 $3.65 37.0%

Related Metrics

Explore detailed financial metrics and analysis for TCRR.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio